Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
117.68
+7.22 (6.54%)
At close: Mar 2, 2026, 4:00 PM EST
117.60
-0.08 (-0.07%)
After-hours: Mar 2, 2026, 4:00 PM EST
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nutex Health stock have an average target of 252.5, with a low estimate of 205 and a high estimate of 300. The average target predicts an increase of 114.56% from the current stock price of 117.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 26, 2025.
Analyst Ratings
The average analyst rating for Nutex Health stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $225 → $205 | Strong Buy | Maintains | $225 → $205 | +74.20% | Aug 26, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $300 | Strong Buy | Reiterates | $300 | +154.93% | Jul 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $225 | Strong Buy | Maintains | $100 → $225 | +91.20% | May 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $150 → $300 | Strong Buy | Maintains | $150 → $300 | +154.93% | May 15, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $60 → $150 | Strong Buy | Maintains | $60 → $150 | +27.46% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
1.00B
from 479.95M
Increased by 108.77%
Revenue Next Year
1.04B
from 1.00B
Increased by 3.69%
EPS This Year
15.56
from 9.69
Increased by 60.54%
EPS Next Year
21.42
from 15.56
Increased by 37.66%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.0B | 1.1B | |
| Avg | 1.0B | 1.0B | |
| Low | 945.0M | 973.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 117.5% | 9.6% | |
| Avg | 108.8% | 3.7% | |
| Low | 96.9% | -2.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 16.21 | 22.85 | |
| Avg | 15.56 | 21.42 | |
| Low | 14.77 | 19.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 67.3% | 46.8% | |
| Avg | 60.5% | 37.7% | |
| Low | 52.4% | 23.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.